Johnson & Johnson
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All JNJ news ›Johnson & Johnson says long-term data boosts Icotyde for plaque psoriasis
Johnson & Johnson’s Icotyde (icotrokinra) posts strong phase 3 plaque psoriasis results after 112 weeks of treatment. Read more here. Dr Derma/iStock via Getty Images - New phase 3 data found that plaque psoriasis patients treated with…
Johnson & Johnson reports at least 72% PASI 90 after two years
ICONIC-LEAD's two-year skin clearance results set a longer follow-up point for Alumis's investigational oral psoriasis drug. PASI 90 response rates stayed at or above 72 per cent through week 112 as Johnson & Johnson NYSEJNJ reported new…
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect
Johnson & Johnson is a diversified healthcare player, but it used to be even more so. The company had a consumer health business through which it offered various over-the-counter healthcare products. Many of them were fairly well-known…
Dawson returns to CJFHC as CEO after tenure at Johnson & Johnson
Velva Dawson. - courtesy Howard University Central Jersey Family Health Consortium (CJFHC), a maternal and child health organization, has named Velva Dawson as chief executive officer, marking a homecoming for the public health leader…
Johnson & Johnson’s Ottava Is Set to Revolutionize Robotic Surgery
Our work is centered around four values that make our industry strong and America exceptional: free enterprise, competitiveness, individual liberty and equal opportunity. The men and women of the NAM’s Board of Directors are committed to…
Pfizer’s Yield Is Three Times Bigger. Johnson & Johnson’s Dividend Has Something Pfizer Does Not
Pfizer's yield towers over Johnson and Johnson's, but a bigger number on paper can hide serious risks underneath. Before you chase that payout, consider what a frozen dividend, rising debt, and a multibillion-dollar write-down actually…
David E. Collins, chairman of Johnson & Johnson’s McNeil Consumer Products during the Tylenol murders, dies
David E. Collins was the chairman of Johnson & Johnson’s McNeil Consumer Products unit, the makers of Tylenol, during the still-unsolved Chicago-area poisoning deaths in 1982 that were caused by drug tampering. Collins became his company’s…
Johnson & Johnson Q3 2026 Earnings Preview — October 13, Street Expects $2.51 EPS
Wall Street is anticipating continued growth momentum when Johnson & Johnson reports third-quarter 2026 results on October 13 before market open. The consen... The post Johnson & Johnson Q3 2026 Earnings Preview — October 13, Street…
RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ)
RBC Capital analyst Trung Huynh maintained a Buy rating on Johnson & Johnson today and set a price target of $290.00. Huynh covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Eli Lilly & Co.…
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Johnson & Johnson (JNJ), Wave Life Sciences (WVE) and Connect Biopharma Holdings (CNTB) with bullish sentiments. Johnson & Johnson (JNJ) In a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
zacks.com409
-
marketscreener.com405
-
theglobeandmail.com277
-
finance.yahoo.com265
-
tradingview.com253
Measured across the 4Houston news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.